Cargando…
Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer
The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these patients. The ability to perform complete cytoreduction depends on the extent of disease and the skills of the surgical team....
Autores principales: | Llueca, Antoni, Climent, María Teresa, Escrig, Javier, Carrasco, Paula, Serra, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047030/ https://www.ncbi.nlm.nih.gov/pubmed/33854085 http://dx.doi.org/10.1038/s41598-021-86928-2 |
Ejemplares similares
-
Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
por: Llueca, Antoni, et al.
Publicado: (2018) -
Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
por: Llueca, Maria, et al.
Publicado: (2023) -
A radiologic-laparoscopic model to predict suboptimal (or complete and optimal) debulking surgery in advanced ovarian cancer: a pilot study
por: Llueca, Antoni, et al.
Publicado: (2019) -
Outcome quality standards in advanced ovarian cancer surgery
por: Llueca, Antoni, et al.
Publicado: (2020) -
Correction to: Outcome quality standards in advanced ovarian cancer surgery
por: Llueca, Antoni, et al.
Publicado: (2020)